T3949

Myristic acid (Crodacid) , a 14 carbon saturated fatty acid, is a rare molecule in cells and is a substrate of some fatty acid desaturases. This compound has the ability to acylate proteins by covalently binding to the N-terminal glycine residues, in a process called N-terminal myristoylation. Myristoylation of substrate proteins by this fatty acid has the potential to activate and mediate many physiological pathways. Furthermore, saturated fatty acids have been reported to be essential for biological activities of lipopolysaccharides and have demonstrated the ability to induce expression of COX-2 and NFκB (nuclear factor κB) activation.

Aclimostat (ZGN-1061) is a highly potent inhibitor of the MetAP2 enzyme, demonstrating promising efficacy and safety profiles in preclinical trials. In a mouse model of obesity and insulin resistance, ZGN-1061 shows comparable weight loss efficacy to beloranib and improves metabolic parameters. Additionally, ZGN-1061 induces consistent changes in gene transcription in HepG2 cells, further supporting its positive pharmacological effects.

FRM-024 is a powerful gamma secretase modulator with the ability to penetrate the central nervous system (CNS), designed specifically for the treatment of familial Alzheimer's disease.

Vemircopan is a complement factor D inhibitor.

(VH032-Boc-trans-3-aminocyclobutanol-Pip-CH2COOH), also known as (S,R,S)-AHPC-Boc-trans-3-aminocyclobutanol-Pip-CH2COOH, is a conjugate compound comprising a ligand-linker that targets E3 ligase and features a VHL ligand on one end. It is employed in PROTAC technology applications.

2-Azido-PEG3-amido-13-biscarboxylethoxypropane is a polyethylene glycol (PEG)-based linker designed for constructing PROTACs.

Thalidomide-O-C5-acid is a chemically synthesized conjugate serving as an E3 ligase ligand-linker, combining the cereblon ligand derived from Thalidomide with a linker commonly used in PROTAC technology.

EZH2-IN-4 is a highly potent EZH2 inhibitor that can be taken orally. It exhibits inhibitory effects against wild type (WT) 5-membered (5-mer) EZH2 and mutant 5-mer EZH2, with IC 50 values of 0.923 nM and 2.65 nM, respectively. Moreover, EZH2-IN-4 has demonstrated significant anti-cancer activity.

Tofersen (BIIB067) is an antisense oligonucleotide (ASO) that mediates RNase H-dependent degradation of SOD1 (superoxide dismutase 1) mRNA, inhibiting SOD1 protein synthesis for potential use in amyotrophic lateral sclerosis (ALS).

Rintodestrant (G1T48) is an orally active, non-steroidal, selective estrogen receptor degrader (SERD) and CDK4/6 inhibitor.

Myristic acid-13C3 is the 13C-labeled form of myristic acid (TMSM-1678), a saturated 14-carbon fatty acid found in many animal and plant fats, particularly in dairy fat, coconut oil, palm oil, and nutmeg oil.

Myristic acid-D3 is the deuterated form of Myristic acid. Myristic acid (T3949) is a saturated 14-carbon fatty acid found in various animal and plant fats, particularly in butterfat, coconut oil, palm oil, and nutmeg oil.

Myristic acid-D7 is the deuterated form of Myristic acid. Myristic acid (T3949) is a saturated 14-carbon fatty acid commonly found in a variety of animal and plant fats, notably in butterfat, coconut oil, palm oil, and nutmeg oil.

Myristic acid-D27 is the deuterated form of myristic acid. Myristic acid (T3949) is a saturated 14-carbon fatty acid found in most animal and plant fats, particularly in dairy fat, coconut oil, palm oil, and nutmeg oil.

Myristic acid-D5 istic acid-D5 is the deuterated form of myristic acid (TMSM-1678). Myristic acid, a saturated fatty acid containing 14 carbon atoms, is commonly found in various animal and plant fats, notably in butterfat, coconut oil, palm oil, and nutmeg oil.

Myristic acid-D2 istic acid-D2 is the deuterated form of myristic acid. Myristic acid (T3949) is a saturated fatty acid with a 14-carbon chain, commonly found in most animal and vegetable fats, notably in dairy fats, coconut oil, palm oil, and nutmeg oil.